U
Zealand Pharma A/S ZLDPF
$75.88 -$7.17-8.63% OTC PK
Recommendation
Prev Close
--
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)

09/30/2025 06/30/2025 03/31/2025 12/31/2024 09/30/2024
Net Income 999.84M 1.02B -170.39M -156.38M -153.01M
Total Depreciation and Amortization 3.42M 3.20M 3.24M 3.36M 3.36M
Total Amortization of Deferred Charges 2.36M 2.36M 2.36M 2.36M 172.70K
Total Other Non-Cash Items 170.46M 149.22M -1.32M -2.01M 12.32M
Change in Net Operating Assets -46.13M -22.74M -7.21M 17.42M 36.28M
Cash from Operations 1.13B 1.16B -173.33M -135.26M -100.87M
Capital Expenditure -2.63M -2.09M -1.85M -1.45M -2.26M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -261.10K -261.10K 3.33M -- --
Other Investing Activities -270.80M -1.03B -801.26M -1.08B -1.10B
Cash from Investing -273.69M -1.03B -799.77M -1.08B -1.10B
Total Debt Issued 0.00 0.00 0.00 369.87M 369.87M
Total Debt Repaid -18.77M -17.53M -16.92M -16.44M -20.49M
Issuance of Common Stock 32.61M 35.82M 7.05B 8.52B 8.54B
Repurchase of Common Stock -407.17M -603.21M -351.83M -351.83M -351.83M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -100.00K -2.46M -213.63M -236.58M -237.06M
Cash from Financing -60.15M -88.00M 932.17M 1.20B 1.20B
Foreign Exchange rate Adjustments -8.73M -25.65M -46.00K 893.00K -626.50K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 787.38M 7.45M -40.99M -15.57M -1.82M